My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Ikena Oncology, Inc. - Common Stock (NQ:IKNA)

1.430 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Ikena Oncology, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Credit Suisse Maintains Outperform Rating for Ikena Oncology: Here's What You Need To Know ↗

March 15, 2023

Via Benzinga

Ikena Oncology Earnings Perspective: Return On Capital Employed ↗

March 15, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

February 14, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

December 27, 2022

Via Benzinga

Ikena Oncology's Return On Capital Employed Insights ↗

November 30, 2022

Via Benzinga

Ikena Oncology Announces New Cancer Program, Shelves Early Asset For Colorectal Cancer ↗

November 28, 2022

Ikena Oncology Inc (NASDAQ: IKNA) nominated a next-generation mitogen-activated protein kinase (MEK)-RAF complex inhibitor, IK-595, as its first development candidate in the RAS pathway.

Via Benzinga

Ikena Oncology: Q3 Earnings Insights ↗

November 07, 2022

Ikena Oncology (NASDAQ:IKNA) reported its Q3 earnings results on Monday, November 7, 2022 at 08:05 AM. Here's what investors need to know about the announcement.

Via Benzinga

Ikena Oncology: Q2 Earnings Insights ↗

August 11, 2022

Ikena Oncology (NASDAQ:IKNA) reported its Q2 earnings results on Thursday, August 11, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Why Ambrx Biopharma Shares Are Trading Higher By Over 550%? Here Are 52 Stocks Moving In Friday's Mid-Day Session ↗

December 09, 2022

Gainers Ambrx Biopharma Inc. (NYSE: AMAM) shares jumped 551.4% to $2.67 after the company announced preliminary Phase 2 results from its ACE-Breast-03 study showing a 57.1% overall response rate.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

October 26, 2022

Gainers

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

August 31, 2022

Gainers

Via Benzinga

Stocks That Hit 52-Week Lows On Monday ↗

October 31, 2022

During Monday's session, 96 stocks hit new 52-week lows.

Via Benzinga

The Daily Biotech Pulse: Precision BioSciences Inks Gene Editing Pact, Athira Pharma's Alzheimer's Candidate Fails, Enanta Sues Pfizer Over COVID-19 Antiviral ↗

June 22, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

October 25, 2022

On Tuesday, 120 companies set new 52-week lows.

Via Benzinga

Carnival Surges Over 12%, Here's 75 Biggest Movers From Friday ↗

June 27, 2022

Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Schenker and USA Truck announced plans to combine and create premier North American transportation...

Via Benzinga

Ikena Oncology Secures Fast Track designation From FDA For Pleural Cancer Candidate ↗

June 22, 2022

Ikena Oncology, Inc. (NASDAQ: IKNA) received Fast Track designation from the U.S. Food and Drug Administration (FDA) for IK-930, in patients with unresectable NF2-deficient malignant pleural...

Via Benzinga

5 Value Stocks To Watch In The Healthcare Sector ↗

June 06, 2022

The Meaning Behind Value Stocks A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

June 01, 2022

Via Benzinga

77 Biggest Movers From Yesterday ↗

June 01, 2022

Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) shares climbed 364% to close at $9.93 on Tuesday after the company announced it has entered into a definitive merger agreement to be acquired by an affiliate...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 05, 2022

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

May 02, 2022

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

April 19, 2022

Gainers

Via Benzinga

HC Wainwright & Co. Maintains Buy Rating for Ikena Oncology, Raises Price Target To $26 ↗

April 13, 2022

HC Wainwright & Co. has decided to maintain its Buy rating of Ikena Oncology (NASDAQ:IKNA) and raise its price target from $25.00 to $26.00. Shares of Ikena Oncology are trading up 7.06% over the last...

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 08, 2022

Gainers Phio Pharma (NASDAQ:PHIO) shares increased by 46.7% to $1.33 during Friday's regular session. As of 13:31 EST, Phio Pharma's stock is trading at a volume...

Via Benzinga

Mid-Morning Market Update: Markets Edge Lower; US Wholesale Inventories Rise 2.5% In February ↗

April 08, 2022

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping 100 points on Friday.

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 08, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 64.4% to close at $1.41 on Thursday. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail...

Via Benzinga

Mid-Afternoon Market Update: S&P 500 Turns Positive; Aptinyx Shares Slide ↗

April 07, 2022

U.S. stocks pared losses, with the Dow Jones and S&P 500 turning positive toward the end of trading on Thursday.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

April 07, 2022

Gainers Trevi Therapeutics (NASDAQ:TRVI) stock rose 45.8% to $2.77 during Thursday's regular session. Trevi Therapeutics's stock is trading at a volume of 15.2...

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

April 07, 2022

Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) jumped 57.6% to $1.3515. Ally Bridge Group reported a purchase of 21.176 million shares of MedAvail Holdings for an average price...

Via Benzinga

Mid-Day Market Update: Dow Tumbles Over 200 Points; Momentus Shares Jump ↗

April 07, 2022

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 200 points on Thursday.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.